Brief: Spago Nanomedical Q4 Sales SEK 4 Thousand
Feb 05 (Reuters) - Spago Nanomedical Q4 net income SEK -5.89 million. Q4 adjusted EPS SEK -0.01 Q4 operating expenses SEK -6.943 million
Feb 05 (Reuters) - Spago Nanomedical Q4 net income SEK -5.89 million. Q4 adjusted EPS SEK -0.01 Q4 operating expenses SEK -6.943 million